The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
Open accessAbstract
BACKGROUND: The long-term impact of allogeneic hematopoietic stem cell transplantation (HSCT) on human immunodeficiency virus type 1 (HIV-1) reservoirs in patients receiving combination antiretroviral therapy (cART) is largely unknown. METHODS: We studied the effects of a reduced-intensity conditioning allogeneic HSCT from donors with wild-type-CCR5(+) cells on HIV-1 peripheral blood reservoirs in 2 patients heterozygous for the ccr5Δ32 mutation. In-depth analyses of the HIV-1 reservoir size in peripheral blood, coreceptor use, and specific antibody responses were performed on samples obtained before and up to 3.5 years after HSCT receipt. RESULTS: Although HIV-1 DNA was readily detected in peripheral blood mononuclear cells (PBMCs) before and 2-3 months after HSCT receipt, HIV-1 DNA and RNA were undetectable in PBMCs, CD4(+) T cells, or plasma up to 21 and 42 months after HSCT. The loss of detectable HIV-1 correlated temporally with full donor chimerism, development of graft-versus-host disease, and decreases in HIV-specific antibody levels. CONCLUSIONS: The ability of donor cells to engraft without evidence of ongoing HIV-1 infection suggests that HIV-1 replication may be fully suppressed during cART and does not contribute to maintenance of viral reservoirs in peripheral blood in our patients. HSCTs with wild-type-CCR5(+) donor cells can lead to a sustained reduction in the size of the peripheral reservoir of HIV-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müßig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802905 · Cited by 1,837
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1240 · Cited by 1,358
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., & Schneider, T. (2011) · Blood · doi:10.1182/blood-2010-09-309591 · Cited by 681
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., & King, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800050105 · Cited by 638
Pereyra, F., Addo, M. M., Kaufmann, D. E., Liu, Y., Miura, T., Rathod, A., Baker, B., Trocha, A., Rosenberg, R., Mackey, E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/526786 · Cited by 540
Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H.-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 342
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Sarantopoulos, S., Stevenson, K. E., Kim, H. T., Cutler, C. S., Bhuiya, N. S., Schowalter, M., Ho, V. T., Alyea, E. P., Koreth, J., Blazar, B. R., et al. (2009) · Blood · doi:10.1182/blood-2008-09-177840 · Cited by 319
Self-citationYukl, S. A., Boritz, E., Busch, M., Bentsen, C., Chun, T.-W., Douek, D., Eisele, E., Haase, A., Ho, Y.-C., Hütter, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003347 · Cited by 291
Self-citationChun, T.-W., Justement, J. S., Murray, D., Hallahan, C. W., Maenza, J., Collier, A. C., Sheth, P. M., Kaul, R., Ostrowski, M., Moir, S., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328340a239 · Cited by 276
Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection
de Roda Husman, A.-M., Koot, M., Cornelissen, M., Keet, I. P. M., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T. L., Prins, M., de Wolf, F., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00004 · Cited by 267
Siliciano, J. D., & Siliciano, R. F. (2005) · Human Retrovirus Protocols · doi:10.1385/1-59259-907-9:003 · Cited by 242
Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
Butler, S. L., Johnson, E. P., & Bushman, F. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3739-3747.2002 · Cited by 238
Duong, Y. T., Qiu, M., De, A. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033328 · Cited by 216
Günthard, H. F., Frost, S. D. W., Leigh-Brown, A. J., Ignacio, C. C., Kee, K., Perelson, A. S., Spina, C. A., Havlir, D. V., Hezareh, M., Looney, D. J., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9404-9412.1999 · Cited by 201
Chun, T., Justement, J. S., Moir, S., Hallahan, C. W., Maenza, J., Mullins, J. I., Collier, A. C., Corey, L., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/518250 · Cited by 197
Bailey, J. R., Lassen, K. G., Yang, H.-C., Quinn, T. C., Ray, S. C., Blankson, J. N., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4758-4770.2006 · Cited by 172
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load
Malnati, M. S., Scarlatti, G., Gatto, F., Salvatori, F., Cassina, G., Rutigliano, T., Volpi, R., & Lusso, P. (2008) · Nature Protocols · doi:10.1038/nprot.2008.108 · Cited by 167
Histone deacetylase inhibitors and HIV latency
Margolis, D. M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328341242d · Cited by 133
Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection
Stewart, G. J., Ashton, L. J., Biti, R. A., Ffrench, R. A., Bennetts, B., Newcombe, N. R., Benson, E. M., Carr, A. D., Cooper, D. A., & Kaldor, J. M. (1997) · AIDS · doi:10.1097/00002030-199715000-00007 · Cited by 110
Effects of Sustained HIV-1 Plasma Viremia on HIV-1 Gag-Specific CD4+ T Cell Maturation and Function
Palmer, B. E., Boritz, E., & Wilson, C. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3337 · Cited by 102
Holland, H. K., Saral, R., Rossi, J. J., Donnenberg, A. D., Burns, W. H., Beschorner, W. E., Farzadegan, H., Rj, J., Quinnan, G. V., Vogelsang, G. B., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-973 · Cited by 101
Response to immunization against polio after allogeneic marrow transplantation.
Ljungman, P. T., Duraj, V., & Magnius, L. O. (1991) · PubMed · Cited by 84
Sharkey, M. E., Babič, D. Z., Greenough, T. C., Gulick, R. M., Kuritzkes, D. R., & Stevenson, M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001303 · Cited by 77
Self-citationEvidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals
Hatano, H., Delwart, E., Norris, P. J., Lee, T., Neilands, T. B., Kelley, C. F., Hunt, P. W., Hoh, R., Linnen, J. M., Martin, J. N., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833dba03 · Cited by 71
Self-citationGandhi, R. T., Bosch, R. J., Aga, E., Albrecht, M., Demeter, L. M., Dykes, C., Bastow, B., Para, M. F., Lai, J., Siliciano, R. F., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/649569 · Cited by 71
Nordøy, T., Husebekk, A., Aaberge, I., Jenum, P. A., Samdal, H., Flugsrud, L. B., Kristoffersen, A., Holte, H., Kvaløy, S., & Kolstad, A. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703228 · Cited by 68
Killian, M. S., Norris, P. J., Rawal, B. D., Lebedeva, M., Hecht, F. M., Levy, J. A., & Busch, M. P. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.640 · Cited by 57
Self-citationMartínez, M. Á., Cabana, M., Ibáñez, Á., Clotet, B., Arnó, A., & Ruiz, L. (1999) · Virology · doi:10.1006/viro.1999.9601 · Cited by 57
Atkinson, K. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb137254.x · Cited by 56
Woolfrey, A. E., Malhotra, U., Harrington, R. D., et al. (2008) · Blood · doi:10.1182/blood-2008-05-157511 · Cited by 40
Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART
Avettand-Fènoël, V., Mahlaoui, N., Chaix, M., Milliancourt, C., Burgard, M., Cavazzana, M., Rouzioux, C., & Blanche, S. (2007) · AIDS · doi:10.1097/qad.0b013e3280b01836 · Cited by 37
Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate
Henrich, T. J., Tsibris, A. M. N., Lewine, N. R. P., Konstantinidis, I., Leopold, K. E., Sagar, M., & Kuritzkes, D. R. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181f25574 · Cited by 25
Self-citationtransplantation Evidence for the cure of HIV infection by CCR5{Delta}32/{Delta}32 stem cell
Schneider, T., Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., & Thiel, E. (2010) · Cited by 18
Cited by
The end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,063
Henrich, T. J., Hanhauser, E., Marty, F. M., Sirignano, M. N., Keating, S., Lee, T.-H., Robles, Y. P., Davis, B. T., Li, J. Z., Heisey, A., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-1027 · Cited by 401
Self-citationImamichi, H., Dewar, R. L., Adelsberger, J. W., Rehm, C. A., O’Doherty, U., Paxinos, E. E., Fauci, A. S., & Lane, H. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609057113 · Cited by 344
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
Katlama, C., Deeks, S. G., Autran, B., Martinez-Picado, J., van Lunzen, J., Rouzioux, C., Miller, M., Vella, S., Schmitz, J. E., Ahlers, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60104-x · Cited by 295
HIV-1 DNA predicts disease progression and post-treatment virological control
Williams, J. P., Hurst, J., Stöhr, W., Robinson, N., Brown, H., Fisher, M., Kinloch, S., Cooper, D., Schechter, M., Tambussi, G., et al. (2014) · eLife · doi:10.7554/elife.03821 · Cited by 293
Metadata
- Authors
- Henrich, T. J., Hu, Z., Li, J. Z., Sciaranghella, G., Busch, M. P., Keating, S. M., Gallien, S., Lin, N. H., Giguel, F. F., Lavoie, L., Ho, V. T., Armand, P., Soiffer, R. J., Sagar, M., LaCasce, A. S., & Kuritzkes, D. R.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-04
- Volume
- 207
- Issue
- 11
- Pages
- 1694-1702
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2126334008
- Cited by
- 262
- References
- 35
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.